Cue Biopharma, Inc. (FRA:1UC)
Germany · Delayed Price · Currency is EUR 0.2440
-0.0030 (-1.21%)
At close: Jan 19, 2026
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of €25.71 million as of January 30, 2026. Its market cap has decreased by -67.75% in one year.
Market Cap
25.71M
Enterprise Value
13.72M
Revenue
6.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.24
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from 187.83M to 25.71M, a decrease of -86.31%. That is a compound annual growth rate of -21.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 25.71M | 8.34% |
| Dec 31, 2025 | 23.73M | -64.42% |
| Dec 31, 2024 | 66.70M | -38.11% |
| Dec 29, 2023 | 107.77M | -6.11% |
| Dec 30, 2022 | 114.78M | -63.66% |
| Dec 31, 2021 | 315.86M | 2.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 40.70M |
| U.C.A. Aktiengesellschaft | 40.20M |
| OTRS AG | 36.22M |
| edding AG | 35.48M |
| Readcrest Capital AG | 32.13M |
| Weng Fine Art AG | 29.08M |
| Biomark Diagnostics | 28.58M |
| Rubean AG | 27.29M |